RLMD

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 2/02/2017
Contact Info
  • 275 Madison Avenue Avenue
  • STE #702
  • New York, NY 10016

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001553643
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 4 a/o Feb 22, 2017
Company Officers/Contacts
Sergio Traversa CEO
Richard M. Mangano, Ph. D Chief Scientific Officer
Company Directors
Charles Casamento
Paul Kelly
Sandesh Seth
Maged Shenouda
Sergio Traversa
Service Providers
Accounting/Auditing Firm
GBH CPAs, PC
6002 Rogerdale
Suite 500
Houston, TX, 77072
United States
 
Securities Counsel
Hiscock & Barclay
One Park Place
300 South State Street
Syracuse, NY, 13202
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Camp Nine, Inc. until 8-2014
RLMD Security Details
Share Structure
Market Value1 $11,434,116 a/o Mar 27, 2017
Authorized Shares 100,000,000 a/o Sep 30, 2016
Outstanding Shares 12,035,912 a/o Feb 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Empire Stock Transfer Inc.
Shareholders
Shareholders of Record 165 a/o Sep 09, 2016
Short Selling Data
Short Interest 2,523 (183.48%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security